Related Experiment Videos
Nocturnal sleep structure and temperature slope in MPTP treated monkeys
H Almirall1, I Pigarev, M D de la Calzada
1Departament de Psiquiatria i Psicobiologia Clinica, Universitat de Barcelona, Spain. ealmirall@psi.ub.es
Journal of Neural Transmission (Vienna, Austria : 1996)
|January 29, 2000
Summary
1-Methyl, 4-phenyl, 1,2,3,6-tetrahydropyridine (MPTP) exposure in monkeys disrupts sleep and lowers body temperature, particularly in motor-impaired subjects. These findings suggest MPTP
Area of Science:
- Neuroscience
- Sleep Medicine
- Toxicology
Background:
- 1-Methyl, 4-phenyl, 1,2,3,6-tetrahydropyridine (MPTP) is a neurotoxin that selectively damages dopaminergic neurons in the nigrostriatal pathway.
- MPTP-induced parkinsonism in non-human primates is a widely used model for studying Parkinson's disease (PD).
- Non-motor symptoms, including sleep disturbances and altered thermoregulation, are common in PD but less understood in MPTP models.
Purpose of the Study:
- To investigate the effects of MPTP on nocturnal sleep patterns and subcutaneous temperature in a primate model.
- To compare sleep architecture and temperature regulation between MPTP-treated monkeys with varying motor deficits and a control subject.
Main Methods:
- Chronic electroencephalogram (EEG), electrooculogram (EOG), and electromyogram (EMG) recordings were obtained during nocturnal sleep.
- Subcutaneous temperature was monitored continuously using radio telemetry.
- Sleep stages and temperature parameters were analyzed in MPTP-treated (motor-disabled and non-motor-disabled) and control monkeys.
Main Results:
- Motor-disabled MPTP-treated monkeys exhibited lighter sleep, reduced slow-wave sleep, and decreased rapid eye movement (REM) sleep compared to the non-motor-disabled monkey.
- Lower subcutaneous temperature values were observed in the motor-disabled MPTP-treated monkeys.
- Individual variations in sleep organization and temperature slopes were noted even among similarly disabled monkeys.
Conclusions:
- MPTP-induced motor deficits in primates are associated with significant alterations in sleep architecture and body temperature regulation.
- The findings suggest that MPTP's effects extend beyond the nigrostriatal system, potentially contributing to non-motor symptoms observed in Parkinson's disease.
- Differential vulnerability within the nigrostriatal system may explain varied motor symptoms, while cumulative toxin effects could underlie non-motor manifestations.